The CD95/CD95L pair plays a manifold role in regulating life and death in the function of the immune system. Examples include CD95/CD95L acting as cytotoxic CD8+ T cell eector molecules, or functioning on CD4+ T helper cells to maintain peripheral tolerance or reestablishing homeostasis. Current understanding of the CD95 signaling pathway reveals several potential regulatory targets, acting both receptor proximally and distally, that can terminate or amplify the receptor's signal. The important and possibly nonredundant role of CD95 is highlighted both in how de®ciencies in functional CD95 or its ligand manifest themselves in autoimmune syndromes, and how uncontrolled cell death results in insucient, or inappropriate immune responses against immune challenge. This review examines CD95-mediated signal transduction, and the eect preferential apoptosis of T helper cell subsets has on immune system biasing.
Introduction
Regulation of the immune system can be broadly divided into two phases. An initiation phase, consisting of recognition, growth, dierentiation and eector function of lymphocytes, and a termination or clonal down-regulation phase . During an immune response there is a dramatic increase in the number of antigen speci®c lymphocytes, however following a successful response, the immune system must restore lymphocyte numbers to basal levels. The observed reduction in lymphocyte numbers is attributed to cell death accomplished using two mechanisms: (i) apoptosis due to neglect and (ii) active-induction of apoptosis.
Appropriate T lymphocyte activation requires two essential signals. The primary signal conferring speci®city to a response, is recognition by the TCR of its cognate ligand presented in association with the major histocompatibility complex on antigen presenting cells (APC) (Medzhitov and Janeway, 1997) . The second signal includes interactions of the T cell with accessory cell surface molecules on antigen-presenting cells or cytokines, together referred to here as costimulation. The precise manner in which costimulatory activation signals supplement TCR signaling is unclear; in their absence though, most T cell responses are aborted. Expression of costimulatory molecules re¯ects the activated state of the innate immune system, thereby promoting expansion of speci®c T cells, and driving their dierentiation toward various eector populations. Late in the eector phase costimulation wanes, depriving T cells of sucient amounts of survival and growth factors initiating death by neglect' .
In contrast, active induction of death relies on T cell activation to upregulate the molecules CD95 and CD95L, responsible for triggering death. Death resulting from autocrine production of CD95L is a feature of T cells that have been repeatedly stimulated through their antigen receptor (Dhein et al., 1995; Brunner et al., 1995; Ju et al., 1995) , and may be a fail safe mechanism preventing inappropriate T cell activation. It has been suggested that this role of CD95 ensures that peripheral tolerance is established or maintained against persistent antigens . This mechanism of deleting cells after repeated stimulation may also be utilized by pathogens to establish chronic infections.
CD95/CD95L
Initiated by a search for cell surface molecules that could regulate malignant lymphocyte growth, development of tumor killing monoclonal antibodies led (Trauth et al., 1989; Yonehara et al., 1989) to the discovery of two 45 ± 52 kd molecules termed APO-1 and Fas. The two antibodies, anti-APO-1 (Trauth et al., 1989) and anti-Fas (Yonehara et al., 1989) were found to abrogate tumor growth mediated by antibody binding alone. Cloning of the cell surface molecules by both groups revealed that the molecules' sequences were identical, and consequently were given the cluster of designation 95 (CD95).
CD95 is a type 1 membrane protein belonging to the tumor necrosis factor receptor superfamily. Included among this rapidly growing family are the receptors TNF-R1, DR3 (APO-3/TRAMP), DR4 (TRAIL-R1) and DR5 (TRAIL-R2). These receptors all share the presence of a TNF family-conserved 68 amino acid region termed the death domain (DD) within the cytoplasmic region, and upon ligation with either cognate ligands or speci®c agonistic antibodies, can activate an apoptosis signaling pathway (Nagata and Suda, 1995) . CD95 ligand is a type II membrane protein belonging to the TNF ligand family. CD95L is expressed as a trimeric molecule either in membranebound or soluble form. Binding of an agonistic antibody or the ligand to CD95 causes receptor clustering which is necessary for death signal initiation (Kischkel et al., 1995) . CD95 has a wide tissue distribution, but is most abundantly expressed in the thymus, liver, heart and kidney (Nagata, 1997) . On the other hand, CD95L is predominantly expressed by activated T lymphocytes and natural killer cells, and also expressed constitutively in`immune privileged sites' (Green and Ware, 1997) .
CD95 signaling pathways
CD95 death signaling is transduced by the clustering of its cytoplasmic region . The death domain, found near the carboxyl terminus of the receptor plays a crucial role in mediating the homotypic recruitment interactions necessary for CD95's signal transduction (Itoh and Nagata, 1993) . Receptor oligomerization results in the rapid recruitment of the death domain-containing adaptor molecule FADD (Fas-associated with death domain) to the receptor Stanger et al., 1995; Chinnaiyan et al., 1995) , followed by the ICE-like protease, caspase-8. FADD and caspase-8 interact via another conserved domain termed the death eector domain. CD95, in association with FADD and caspase-8 form the functional death inducing signaling complex (DISC) (Muzio et al., 1996) . Caspase-8, as with all known caspases, exists in the cytosol in an inactive form, with very low inherent proteolytic activity. On prolonged triggering of CD95, the pro-caspase-8 recruited to the DISC is autoproteolytically cleaved . It is believed that induced proximity, aorded by recruitment to the DISC, permits pro-caspase-8's low proteolytic activity to process similarly recruited, neighboring caspase-8 molecules (Martin et al., 1998; Muzio et al., 1998; Yang et al., 1998) .
The cleavage of pro-caspase-8 gives rise to two active fragments p18 and p10 that are released into the cytosol (Muzio et al., 1996) where they act on procaspase-3 and other downstream caspases, that include caspase-6 and -7 (Salvesen and Dixit, 1997).
Ligation of CD95 can also induce an alternate mitochondria-dependent signaling pathway. In this pathway a small amount of pro-caspase 8 is recruited to the DISC. The amount of activated caspase-8 is insucient to trigger directly the caspase cascade (Scadi et al., 1998a) , but can cleave BID, a BH3 domain-containing pro-apoptotic protein of the Bcl-2 family (Li et al., 1998) . Cleavage of BID causes its translocation to the mitochondria. The c-terminal product of cleaved BID, the active pro-apoptotic form, induces the clustering of mitochondria around the nucleus, followed by release of cytochrome c. Cytochrome c in association with apoptotic protease activating factor (Apaf-1) initiates pro-caspase-9 processing, which in turn activates pro-caspase-3, and other downstream caspases (Susin et al., 1997) . Scadi et al. (1998a) reported that distinct cell types utilize either of the two CD95 signaling pathways, restrictively. Cells that employ direct caspase-8-mediated activation of pro-caspase 3 were called Type I cells, and cells that initiate pro-caspase-3 activation through induction of mitochondrial damage were termed Type II cells.
The molecular ordering of the CD95-FADDcaspase-8 pathway is currently the best understood signal transduction pathway of CD95-mediated apoptosis. However, using the yeast two-hybrid system, additional proteins have been identi®ed that activate alternative CD95 signal transduction pathways. Receptor interacting protein (RIP) can associate with CD95 through its death domain . RIP has been shown to activate caspase-2, through an interaction with the adaptor molecule, RAIDD (Duan and Dixit, 1997) . CD95 ligation can also activate the JNK kinase pathway (Wilson et al., 1996) , that is initiated by the binding of Daxx (Yang et al., 1997) to the receptor. In contrast to FADD and RIP, Daxx's interaction with CD95 does not appear to depend on a death domain/death domain interaction (Yang et al., 1997) . In CD95-sensitive cells, receptor ligation also catalyses the hydrolysis of sphingomyelin, which results in a rapid increase in the endogenous level of ceramide, (Nagata and Golstein., 1995; Gulbins et al., 1995; Tepper et al., 1995) which is associated with activation of caspases. The sphingomyelinase/ceramide pathway can be further augmented by a protein tyrosine phosphatase called hematopoietic cell phosphatase (HCP) (Su et al., 1995) .
Despite the potential of the above described molecules to signal for death, mice with targeted deletions of FADD (Yeh et al., 1998) , caspase-8 (Varfolomeev et al., 1998) , caspase-9 (Hakem et al., 1998 , Kuida et al., 1998 , and acid sphingomyelinase (Santana et al., 1996) , indicate that the FADD/caspase-8 signaling pathway is the primary, and probably nonredundant pathway in inducing death via CD95. It is conceivable that depending upon the endogenous availability of caspase-8, dierent cell types engage speci®c signaling pathways following receptor ligation. This possibility raises the need to reevaluate the role of other molecules, besides FADD/caspase-8, in CD95 signaling in primary, untransformed lymphoid cells.
Inhibitors of CD95-mediated apoptosis
CD95-mediated apoptosis can be blocked by naturally occurring protein inhibitors. Cytokine response modi®er A(Crm A), a serpin from cowpox virus (Ray, 1992) and p35 from baculovirus, (Xue and Horvitz, 1995; Bump et al., 1995) can both prevent apoptosis by serving as non-cleaveable substrates for ICE-related caspases.
A new viral gene product designated viral FLICEinhibitory protein (v-FLIP), has been described. v-FLIP has two death eector domains and resembles the N-terminal half of caspase-8. A cellular homologue of v-FLIP, termed c-FLIP, has been shown to exist in mammalian cells (Irmler et al., 1997) . c-FLIP contains two DEDs, but also a caspase-like domain. However, c-FLIP lacks the amino acid residues in the caspaselike catalytic site that are essential for proteolytic activity. Stable, over expressing transfectants of c-FLIP protein block CD95-mediated apoptosis (Irmler et al., 1997) by competing with caspase-8 for recruitment to the DISC and preventing caspase-8 processing (Scadi et al., 1998b) .
Sentrin is a death domain containing molecule that can prevent apoptosis by binding to the death domain of CD95 (Okura et al., 1996) , thereby preventing FADD recruitment to the DISC.
Recently a protein named TOSO was identi®ed, with its negative eect on T cell apoptosis being linked to an absence of active caspase-8 following death induction, possibly through an upregulation of c-FLIP (Hitoshi et al., 1998) .
The Bcl-2 family and the mitochondrial apoptotic checkpoint Long appreciated as regulators of cell death, the Bcl-2 family of proteins counts as members proteins that can protect against (Bcl-2, Bcl-xL), and promote (BAD, BAX, BAK, BID) apoptosis induced by a variety of stimuli. A hallmark feature of this family is the ability of its members to form dimers with other members of the family, using conserved Bcl-2 homology (BH-1, 2, 3) domains (Chao and Korsmeyer, 1998) . The ratio between anti-apoptotic homodimers, anti-apoptotic/ pro-apoptotic heterodimers and pro-apoptotic homodimers seems to determine sensitivity to apoptosis. Dimerization partners are selected in part by posttranslational modi®cations. Phosphorylation of Bcl-2 prevents its ability to inhibit apoptosis (Haldar et al., 1995) . In contrast, hyperphosphorylation of BAD (Zha et al., 1996) prevents its heterodimerization with Bcl-2 and Bcl-xL, thereby blocking apoptosis. An understanding of the molecular interactions responsible for regulating death are derived from studies examining the eect of cytokine withdrawal on cells' susceptibility to apoptosis. The presence of growth factors stimulates the phosphorylation of BAD by Akt (Dattu et al., 1997; Del Roso et al., 1997) on two serine residues (Zha et al., 1996) . Phosphorylated BAD no longer heterodimerizes with Bcl-2/Bcl-xL, and remains in the cytoplasm, bound to the protein 14-3-3, where BAD is innocuous. However, upon cytokine withdrawal, BAD is dephosphorylated, and can heterodimerize with Bcl-2/Bcl-xL, which prevents Bcl-2/Bcl-xL's anti-apoptotic function.
A shared feature among apoptotic stimuli, whether they are initiated by growth factor withdrawal, radiation-induced damage or chemical treatment, is that the signals generated converge at a mitochondrial checkpoint (Green, 1998) . The mitochondria undergo characteristic changes that correlate with cell death induction. Documented changes include mitochondrial swelling, disruption of the mitochondrial outer membrane, inner membrane depolarization, and the release of cytochrome c to the cytoplasm (Liu et al., 1996; Vander Heiden et al., 1997) . Of the several changes occurring to the mitochondria, only the release of cytochrome c has been proven necessary to engage downstream apoptosis machinery (Liu et al., 1996) . The remaining alterations appear to result from, rather than cause apoptosis (Bossy-Wetzel et al., 1998), however occurrence of all these events is inhibited by over expression of Bcl-2/Bcl-xL (Vander Heiden et al., 1997) . By preventing apoptosis-related mitochondrial alteration, cell death in response to the above stimuli is blocked (Kluck et al., 1997) .
Despite the clear role that the anti-apoptotic Bcl-2 family members play in providing protection from a number of apoptotic stimuli, it remains controversial whether or not these proteins can confer protection against CD95-mediated apoptosis. Results seem to depend on the model system used. Reports vary from complete protection (Takayama et al., 1995; Jaattela et al., 1995; Lee et al., 1996; Mandal et al., 1996; Vander Heiden et al., 1997) , through partial protection (Itoh et al., 1993; Memon et al., 1995; Boise et al., 1995; Boise and Thompson, 1997) , to no protection (Chiu et al., 1995; Strasser et al., 1995; Chinnaiyan et al., 1996; Memon et al., 1995) . These dierences can now be somewhat explained by a recent study comparing the CD95 signal transduction pathway in a number of cell types (Scadi et al., 1998a) . Cells were classi®ed as Type I, or Type II, depending on utilization of exclusively one of two distinct CD95 signaling pathways. Type I cells utilize a pathway that is mitochondria-independent, and bypass the Bcl-2 regulatory checkpoint. In contrast, in Type II cells, Bcl-2 and Bcl-xL proteins protect from apoptosis since they utilize the alternative mitochondria-dependent CD95 signaling pathway that is sensitive to the presence of Bcl-2 and Bcl-xL.
Fas signaling in naive murine and freshly isolated human T cells
Expression of CD95 and CD95L is tightly regulated in T cells. Naive (CD45RA+) T cells express low amounts of CD95 that is upregulated after activation. On the other hand, previously activated (CD45RO+) T cells express CD95 constitutively. CD95L is not expressed constitutively on either the nave, or CD45RO+ T cell populations, but is rapidly upregulated following activation . NaõÈ ve murine T cells (Refaeli et al., 1998) , and freshly isolated, human T cells , following activation are, despite the surface expression of CD95, resistant to apoptosis. The resistance to CD95-mediated apoptosis of activated T cells is transient, lasting several days, and is regulated at the level of CD95 signaling . DISCs of activated human peripheral T cells are incapable of recruiting, and processing caspase-8 (Scadi et al., 1998b , thus are defective in subsequent activation of death eector molecules. In naõÈ ve murine T cells, reacquisition of a CD95 sensitive phenotype is potentiated by culture in IL-2 (van Parijs and Abbas, 1997; Lenardo, 1991) , and is suggested to be a consequence of c-FLIP down regulation (Refaeli et al., 1998) . DISC analysis of activated human T cells demonstrates that the endogenous levels of c-FLIP are insucient to compete, and block caspase-8 recruitment to the DISC. These results imply c-FLIP plays a minor role in the apoptosis resistance of freshly isolated, in vitro activated human T cells. To date the mechanism that recently activated human T cells use to escape CD95 mediated death is unknown, however the presence of an additional, as yet unidenti®ed factor associated with CD95 has been observed and may play a role (Scadi et al., 1998a) . The part c-FLIP plays in murine T cell DISC assembly still needs to be addressed.
Fas-mediated cell death in Th1 and Th2 type cells.
In contrast to the above described studies, which utilized T cells having undergone one round of stimulation/antigen exposure; studies described below utilize cells that have undergone several rounds of in vitro expansion, thus represent mature eector T cells that exert an immuno-modulatory eect. Mature CD4 T cells can be divided into two distinct subsets based on the type of cytokines they produce upon activation (Janeway et al., 1998; Mosmann and Coman, 1989; Salgame et al., 1991) . The Th1 subset produces IFN-g and IL-2, and are required for cellular immune responses. On the other hand, Th2 cells produce IL-4, IL-5 and IL-10 and promote humoral immunity. The decision of a naive CD4+ T cell to dierentiate into a Th1 or Th2 cell in response to antigen is crucial since it determines whether a cell-mediated or humoral immune response will be made against a particular pathogen. The biological relevance of this decision in infectious disease is underscored by the ability of Th1 and Th2 cells to in¯uence disease outcome . For example, protection against most intracellular pathogens requires cellmediated immune responses generated by Th1 cells, but deviation of the host immune response to a Th2-type response, promoting humoral immunity, results in disease. Several factors determine whether a proliferating CD4+ T cell will dierentiate into a Th1 or a Th2 cell. Antigen dose (Bretscher et al., 1992) , ligand density (Pfeier et al., 1991) , intracellular secondary signaling pathways (Novak and Rothenberg, 1990), antigen-presenting cells (Weaver et al., 1998) with their co-stimulatory signals (Gajewski et al., 1990; Kuchroo et al., 1995) and cytokines themselves (Seder and Paul, 1994; Swain et al., 1990) all have an eect. In addition to the well-described cytokine pro®le of the T cell subsets, other phenotypic changes accompany differentiation. Among a host of recently described dierences such as cytokine receptor expression (Szabo et al., 1997) , selectin expression (Austrup et al., 1997) and chemokine receptor expression (Sallusto et al., 1998) is the dierential ability of T cell subsets to undergo CD95 mediate death following re-activation (Varadhachary et al., 1997; Zhang et al., 1997) .
Because apoptosis of mature T cells is a powerful mechanism for deleting T cells, it raises the interesting possibility that unequal apoptosis of Th1 and Th2 eector cells may lead to preferential deletion of one subset over another. Prior to stimulation, previously activated T cells of both subsets are susceptible to CD95 death signaling, however following reactivation dierences in susceptibility between Th1 and Th2 cells appear. Activated Th1 cells are described as being more susceptible to CD95-mediated apoptosis compared to activated Th2 cells. One study (Ramsdell et al., 1994) reports that cells committed to the Th1 lineage are preferentially susceptible to apoptosis as a result of increased CD95L expression. Another study (Zhang et al., 1997) indicates that the dramatic dierence between CD95-mediated cell death in Th1 and Th2 eector populations results from high intrinsic expression of the CD95 signal inhibitor Fas associated phosphatase (FAP) (Sato et al., 1995) in Th2 cells. Studies from our laboratory analysing human Th1 and Th2 clones (Varadhachary et al., 1997) agree with the above studies regarding the apoptotic phenotype of Th1 versus Th2 cells, but dier as to the basis behind resistance to apoptosis. The observed dierence in sensitivity to apoptosis of the two subsets is not due to dierences in the expression levels of either CD95, CD95L or the FAP protein, but due to signals generated by CD3 ligation. Signals generated upon CD3 ligation in Th2 cells protects those cells from CD95-mediated apoptosis. In contrast, the signals generated by Th1 cells are not protective.
Although the mechanisms reported in the above studies explaining dierential apoptosis of Th1 and Th2 cells are dierent, the data nevertheless strongly indicate that CD95-mediated apoptosis may play a critical role in regulating the delicate balance of the two subsets in response to antigenic rechallenge.
Consequences of preferential T helper 1 cell subset apoptosis
Intracellular pathogens may exploit Th1 cell down regulation for their own survival. The results described above indicate that by activating Th1 cells using anti-CD3, which is akin to antigen recognition without costimulation, apoptosis of Th1, but not Th2 cells occurs. In some instances, costimulation protects T cells from stimulation induced apoptosis (Boise et al., 1995) , thus it is possible that intracellular pathogens have evolved ways to down regulate antigen presenting cell costimulatory molecules, and induce selective T cell apoptosis. In vivo, selective apoptosis of Th1 cells would lead to an immune bias that promotes humoral immunity, which is ineective for combating intracellular pathogens.
A potent mechanism for altering macrophage costimulatory molecule expression is through modulation of the macrophage's cytokine microenvironment. Macrophages are activated to secrete both pro and anti-in¯ammatory cytokines upon invasion by intracellular pathogens. IL-12 secreted by activated macrophages biases naive T cells to dierentiate into Th1 cells (Trincheiri, 1998; Scott, 1998) , and reciprocally IL-10 favors Th2 subset development (Powrie et al., 1993) . IL-12 through its ability to induce IFN-g from T and NK cells, upregulates macrophage costimulatory functions. Conversely, macrophage secretion of IL-10, results in down regulation of costimulatory molecules. Thus through their ability to induce either IL-10 or IL-12, pathogens can alter accessory costimulatory functions of macrophages to their advantage. These alterations in APC function negatively aect the ability of Th1 cells to be appropriately activated, hence introduce immune system bias favoring survival of the pathogen. Support for such a paradigm comes from a number of studies demonstrating that pathogens can alter macrophage costimulatory capabilities.
Macrophages infected with Mycobacterium tuberculosis are refractory to IFN-g activation, and are compromised in their ability to present antigens to T cells (reviewed in Chan and Kaufman, 1994) . During schistosome infection macrophage expression of the costimulatory molecules B7-1 and B7-2 is down regulated , and a progressive increase in apoptosis of activated T cells is observed in conjunction with a decrease in T cell function (Ameisen et al., 1994) . Absence of Th1 cells in HIV-infected individuals is not due to lack of their induction, nor due to their down modulation by an increasing Th2 cell population, rather appears to be due to rapid Th1 cell apoptosis (Ledru et al., 1998) following activation in the absence of costimulation. Addition of blocking antibodies to the cytokine IL-10, or addition of the Th1-promoting cytokine IL-12 restores in vitro T cell proliferative responses and prevents apoptosis of the Th1 cells (Clerici et al., 1993; Ameisen et al., 1994) . Additionally, T cells from individuals infected with either the Epstein-Barr virus (Akbar et al., 1993) or the varicella-zoster virus (Akbar, 1993 ) also undergo extensive activationinduced apoptosis in vitro. The disease models all share the common feature of requiring a Th1-based cellular immune response to resolve infection, suggesting that a related strategy may be employed by pathogens to ensure selective apoptotic depletion of Th1 cells.
Conclusions
Increasing knowledge of CD95 mediated apoptosis makes evident that each enzymatic stage of the death pathway is regulated. Although CD95 signaling in many cell types leads irrevocably to death, there are important examples that demonstrate mere expression of CD95/CD95L is not sucient to confer sensitivity to apoptotic signaling. Two factors that control CD95 susceptibility in T cells are activation state and dierentiative status. Pathogens have evolved strategies that take advantage of the dierences between Th1 and Th2 cells' susceptibility to apoptosis to ensure their own survival. By more precisely understanding how activation and dierentiation aect CD95 signaling, rationale methods for preventing pathogen subversion of the immune system might be implemented.
